Please consult a doctor. Your hate is pathologic.
You show ignorance and NO real knowing what´s going on. Please stop confusing this audience with your brainless posts. Thank you!
Dead money is shorts not covering so they sell their homes so they can pay alimony to your wives after they realize you had no clue and lost everything........oh yes ....Longs have lost nothing and not paying any interest. But good to see you cousin eddie
Freeze, NO. The cap-ex spend by WIN of hundreds of millions will go to upgrade in part existing Plant, so for example to expand the speed of internet for people on the 235,000 mile of copper for better voice, video and internet, WIN will lay new fiber on top of the existing copper lines. No way to start to hack up the streets again and get new rights of way etc etc, SO that new fiber on top of the old copper lines is NOW OWNED BY CSAL., NOT WIN. Understand now.
What a bust of a keynote. Google is leading an army of mutineers, obfuscates, and outright abusers of their OS. We are watching a company spinning its wheels with a disjointed business model in disarray.
Let the best students get into the best schools regardless of race. That used to be the American way.
MOUNT PLEASANT, MI — Inhaling the vapor from e-cigarettes could lead to emphysema, according to researchers at Central Michigan University.
Electronic cigarettes, or e-cigarettes as they're more commonly known, are battery-operated devices that turn nicotine, flavor and other chemicals into an aerosol that is inhaled by the user, according to the U.S. Food and Drug Administration. The liquid vaporized by e-cigarettes comes in countless flavors from menthol to marshmallow.
E-cigarette purveyors tout them as a tar- and tobacco-free alternative to traditional cigarettes and a way to kick a nicotine habit. But according to new research by Central Michigan University College of Medicine's Neeraj Vij, an associate professor of molecular and cell biology, they might not be a safe alternative to smoking.
Vij, research fellow Prashanth Shivalingappa and CMU seniors Colin Westphal of Linden and Rachel Hole of Oakland examined how e-cigarette vapor compared to tobacco smoke by testing how the vapor affects cells, according to a CMU news release.
"The team found even minimal exposure of e-cigarette vapor for one hour, disrupted the protein processes in cells," the release states. "It is the same path cigarette smoke and second-hand smoke takes in our bodies."
According to Mayo Clinic, emphysema gradually damages alveoli, the air sacs in the lungs, causing shortness of breath that progressively worsens. It is one of several diseases known collectively as chronic obstructive pulmonary disease, or COPD, and smoking is the leading cause...
I believe you, i bought most of my shares at 11cents. My cost basis is 33 cents…..15k shares strong
Very impressive slide as these patients had no other treatment options available! The Method B activation also had impressive results and bodes well for Phase II trial with even better QOL and survival for these patients plus now in multiple countries, US, UK , Canada and Germany is my guess.
I bet Mr. Woodford is smiling today and will be there for further funding going forward. Visionary as institutional investor to say the least!
By the way thumbs down was me as I hit wrong button!
Sentiment: Strong Buy
In a research report issued today, Chardan Capital analyst Gbola Amusa initiated coverage on shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) with a Buy rating and a $14 price target, which implies an upside of 14% from current levels.
Amusa wrote, “On 26 May 2015, the EMA granted Accelerated Assessment to the oral small molecule pharmacological chaperone, migalastat, Amicus Therapeutics’ flagship precision medicine for Fabry Disease. This promising development may signal favorable regulatory (and possibly reimbursement) stances for the company’s key asset, as a consequence of what we see as compelling phase III clinical data produced to date. With accelerated US approval also possible, Amicus may see migalastat enter both US and EU markets in 2016, putting the compound on firm footing to achieve what we model as $542 million in 2020E sales (versus consensus of $274 million), en route to $964 million in 2025E sales.”
“Recall that, on 7 May 2015, we recommended Amicus, expecting upside for shares, on our view of Amicus as a potential M&A target in the rare disease space. Given the threat that migalastat poses for products from Shire and Sanofi, as we think is supported by the favorable 26 May EMA news, we continue to see Shire and Sanofi as potential acquirers of Amicus.”, the analyst added.
I am sure Btendo added some value in reducing the engine size. Their original technology was flawed and they have to improve MVIS technology.
I know this stuff is difficult for you to grasp because you haven't seen it in real life. So let me put it in simpler terms..We have trained diplomats who are professionals and run the Consular Office at an Embassy. It's their job to interview visa applicants and determine if we should issue them a visa to come to the U.S. My wife was office manager of the consular office in China. So the professionals interview an applicant..and reject him for the visa..But it isn't over..The rejected Chinaman writes to several U.S. Congressmen/women who know nothing about him. The congressman, being a politician..writes a nasty letter to our Embassy, taking sides with the Chinaman whom he has never met..and eventually, as I have mentioned previously..My wife would be told to just hold her nose and sign it! So this guy gets one of several types of visas..it makes no difference what type because once on American Soil..he is free to change his status to the one best suited toward his path to an American Passport (as a citizen)..That's what he wanted..Now he returns to China under the protection of the American Government..I see this in countries all over the world because I can easily recognize it although you don't..We have an immigration system, that would work pretty well..but unfortunately..the professionals don't operate it..POLITICIANS DO! Of course this gigantic problem has now been overtaken by events..Our boarder has collapsed and anyone, and every one can now simply walk into our country as an army of foreign invaders..We haven't the slightest idea as to who or what is in our country today. All other major civilizations have fallen from the inside..Why should we think ours is different?
Hoping others get cancer now? Gale couldn't cure it anyway. You are a sad vomiting I,I,I little troll. Now go buy some plugs and stick em. Lololololol
I agree 100%
Bloomberg: " ...More than half of these members of the 100% Club have one thing in common: they are biotechnology companies working on medicines for rare diseases, also known as 'orphan drugs'.
Investment banks have their favored lists of potential biotech targets. Goldman Sachs Group Inc.'s list in April included Alkermes Plc, Ariad Pharmaceuticals Inc., Atara Biotherapeutics Inc., BioMarin Pharmaceutical Inc., Clovis Oncology Inc., Synageva BioPharma Corp., Regeneron Pharmaceuticals Inc. and Vertex Pharmaceuticals Inc. That list, of course, has gotten shorter: Alexion Pharmaceuticals Inc. agreed to acquire Synageva for $8.4 billion this month, offering a 120 percent premium to the stock price...."
Sentiment: Strong Buy
The direction from the company has always been a smart phone product in the second half of the year. July is around the corner. Wake up market it is time to buy this stock cause it is coiling and ready to spring to the ceiling. $$$$